Top Banner
ENDOCRINE DISORDERS AND THERAPEUTIC MANAGEMENT Gladys T. Cruz
48
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Endocrine disorders and therapeutic management

ENDOCRINE DISORDERS AND

THERAPEUTIC MANAGEMENT

Gladys T. Cruz

Page 2: Endocrine disorders and therapeutic management

Diabetes Mellitus

Page 3: Endocrine disorders and therapeutic management

Diabetes Mellitus

Is a disorder of the endocrine system that causes alterations in glucose metabolism.

Page 4: Endocrine disorders and therapeutic management

Diabetes Mellitus: Type

Type 1 – an absolute lack of insulin

Type 2 – relative lack of insulin

Page 5: Endocrine disorders and therapeutic management

Diabetes Mellitus

Pancreas is an organ with both endocrine and exocrine functions

- Exocrine function is to release a juice full of enzymes and other components that helps with the process of digestion

Page 6: Endocrine disorders and therapeutic management

Diabetes Mellitus

- Endocrine function (islets of langerhans)

Beta cells produce insulin

Alpha cells produce glucagon

Delta cells produce somatostatin

Page 7: Endocrine disorders and therapeutic management

Diabetic Ketoacidosis

Page 8: Endocrine disorders and therapeutic management

Diabetic Ketoacidosis

1. Beta cells have the inability to produce insulin

2. Hyperglycemia – hyperosmolar state

3. Electrolyte shifts and total body dehydration

4. Formation of ketones because of breakdown of fats and protein

Page 9: Endocrine disorders and therapeutic management

Diabetic Ketoacidosis: Clinical Manifestations Dehydration Ketosis Metabolic

acidosis

Weakness Anorexia Altered mental

status Tachycardia Kussmaul

respirations

Page 10: Endocrine disorders and therapeutic management

Diabetic Ketoacidosis: Goals of Treatment Correction of acidosis Correction of electrolyte and fluid

disturbances Insulin to lower serum glucose levels Prevention of ketosis Prevention of complications

Page 11: Endocrine disorders and therapeutic management

Diabetic Ketoacidosis: Treatments Closely monitor blood glucose levels

and acidosis Replace fluids and electrolytes Administer insulin Monitor cardiac, pulmonary,

neurologic systems

Page 12: Endocrine disorders and therapeutic management

Diabetic Ketoacidosis: Treatments Identify and correct precipitating event Educate the patient and the patient’s

family

Page 13: Endocrine disorders and therapeutic management

Diabetic Ketoacidosis

Rapid insulin

0.1 to 0.2 U/kg/hr

Page 14: Endocrine disorders and therapeutic management

Hyperosmolar Nonketotic Coma

Page 15: Endocrine disorders and therapeutic management

Hyperosmolar Nonketotic Coma

A serious metabolic complication, usually seen in type 2 diabetes

Results in dehydration and electrolyte disturbances without acidosis

Page 16: Endocrine disorders and therapeutic management

Hyperosmolar Nonketotic Coma: Clinical Manifestation

Profound dehydration

Hypotension Tachycardia Diminished CVP

Dry mucous membrane

Poor skin turgor Neurologic

impairments including confusion, seizures and coma

Page 17: Endocrine disorders and therapeutic management

Hyperosmolar Nonketotic Coma

Treatment goals are similar to the interventions of DKA

Page 18: Endocrine disorders and therapeutic management

Hypoglycemia

Page 19: Endocrine disorders and therapeutic management

Hypoglycemia

Occurs when the blood sugar levels drop rapidly

Page 20: Endocrine disorders and therapeutic management

Hypoglycemia

Sweating, tremors

Blurred vvision, hunger, weakness

Behavior changes, and confusion

Anxiety, paresthesia and poor coordination

Slurred speech, headache

Palpitation, nausea

Page 21: Endocrine disorders and therapeutic management

Hypoglycemia: Treatment Fast acting carbohydrates (if client is

conscious)

- ½ cup orange juice

- 4 oz cola

- 4 oz orange juice

Page 22: Endocrine disorders and therapeutic management

Syndrome of Inappropriate Secretion of Antidiuretic Hormone

Page 23: Endocrine disorders and therapeutic management

Syndrome of Inappropriate Secretion of Antidiuretic Hormone

Patient has an excess of antidiuretic hormone secreted into the bloodstream, more than amount needed to maintain normal blood volume and serum osmolality

Page 24: Endocrine disorders and therapeutic management

Syndrome of Inappropriate Secretion of Antidiuretic Hormone

Excessive water is resorbed at the kidney tubule, leading to dilutional hyponatremia

Page 25: Endocrine disorders and therapeutic management

Assessment

Early Clinical Manifestation:

- dilutional hyponatremia include lethargy, anorexia, nausea and vomiting

Page 26: Endocrine disorders and therapeutic management

Assessment

Symptoms of Severe Hyponatremia:

- inability to concentrate, mental confusion, apprehension, seizures, decreased level of consciousness, coma and death

Page 27: Endocrine disorders and therapeutic management

Nursing Diagnoses

Excess Fluid Volume related to comprised regulation mechanism

Anxiety related to lack of control over current situation or disease progression

Deficient Knowledge: Discharge Regimen related to lack of previous exposure to information

Page 28: Endocrine disorders and therapeutic management

Medical Management

Fluid restriction Sodium replacement Medications that increase renal water

excretion (Demeclocycline)

Page 29: Endocrine disorders and therapeutic management

Nursing Management

Restriction of Fluids

- accurate intake and output

- mouth care for fluid restriction

- weigh patient to gauge fluid retention or loss of body fluid

Page 30: Endocrine disorders and therapeutic management

Diabetes Insipidus

Page 31: Endocrine disorders and therapeutic management

Diabetic Insipidus

Caused by a deficiency in the production or release of ADH by the posterior pituitary gland

Page 32: Endocrine disorders and therapeutic management

Diabetic Insipidus:

Neurogenic Nephrogenic Psychogenic

Page 33: Endocrine disorders and therapeutic management

Diabetic Insipidus: Clinical Manifestations Polyuria Polydipsia Hypotension Tachycardia Weight loss Dehydration Mental status

changes

Seizures Constipation

Page 34: Endocrine disorders and therapeutic management

Diabetic Insipidus: Medication

Vasopressin

Desmopressin acetate ( for chronic neurogenic)

Page 35: Endocrine disorders and therapeutic management

Diabetic Insipidus: Nursing Management Monitor intake and output

Page 36: Endocrine disorders and therapeutic management

Thyroid Storm

Page 37: Endocrine disorders and therapeutic management

Thyroid Storm

Also called Thyroid Crisis A complication of pre - existing

hyperthyroidism

Page 38: Endocrine disorders and therapeutic management

Thyroid Storm

Increase in cellular oxygen consumption

Page 39: Endocrine disorders and therapeutic management

Thyroid Storm: Medical Management Prevent cardiovascular collapse Reduce hyperthermia Reverse dehydration

Page 40: Endocrine disorders and therapeutic management

Thyroid Storm: Pharmacologic Management

A. Drugs that block thyroid synthesis

Propylthiouracil (PTU) = blocks conversion of T4 to T3

B. Drugs that block release of thyroid hormone

Iodides = decreases thyroid hormone production

Page 41: Endocrine disorders and therapeutic management

Thyroid Storm: Pharmacologic Management

C. Drugs that block catecholamine effect

Propanolol

Page 42: Endocrine disorders and therapeutic management

Thyroid Storm: Nursing Management Medication administration Normalize temperature Rehydration and correction of

metabolic derangements

Page 43: Endocrine disorders and therapeutic management

Myxedema Coma

Progressive worsening or terminal stage of hypothyroidism

Page 44: Endocrine disorders and therapeutic management

Myxedema Coma

Cell is unable to maintain processes necessary to sustain life

- protein synthesis is curtailed

- carbohydrates and fat metabolism is incomplete

- lipolysis is ineffective, and cholesterol collects in the blood stream

Page 45: Endocrine disorders and therapeutic management

Myxedema Coma: Clinical Manifestation Dull and mask-like face Damaged cardiac myocytes due to

interstitial edema Pleural effusions ADH levels is increased Decreased gastric motility Heat production decreases

Page 46: Endocrine disorders and therapeutic management

Myxedema Coma: Pharmacologic Management

Levothyroxine

Page 47: Endocrine disorders and therapeutic management

Myxedema Management: Nursing Management

Ventilatory support ABG’s measurement ECG monitoring Measures to avoid skin breakdown Manage constipation Monitor I and O

Page 48: Endocrine disorders and therapeutic management

Education’s purpose is to replace an empty mind with an open one.